Pricing

Spectrum Pharmaceuticals Inc. (SPPI)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Thomas J. Riga
Employees:
160
11500 S. EASTERN AVE., SUITE 240, HENDERSON, NV, 89052
702-835-6300
    Formally known as:
  • Neotherapeutics Inc
Stock Split History
DateRatio
2002-09-06 1:25
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. Anti-CD20-IFNa is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available